Is It Too Late To Consider Buying Astrana Health, Inc. (NASDAQ:ASTH)?
Is It Too Late To Consider Buying Astrana Health, Inc. (NASDAQ:ASTH)?
Astrana Health, Inc. (NASDAQ:ASTH), is not the largest company out there, but it received a lot of attention from a substantial price increase on the NASDAQCM over the last few months. The recent rally in share prices has nudged the company in the right direction, though it still falls short of its yearly peak. As a stock with high coverage by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. But what if there is still an opportunity to buy? Let's take a look at Astrana Health's outlook and value based on the most recent financial data to see if the opportunity still exists.
阿斯利康公司(纳斯达克股票代码:ASTH)并不是目前最大的公司,但由于纳斯达克指数在过去几个月中大幅上涨,它受到了广泛关注。尽管仍未达到年度峰值,但最近股价的上涨推动该公司朝着正确的方向前进。作为一只受分析师高度关注的股票,你可以假设该公司前景的任何最近变化都已计入该股。但是,如果还有机会购买呢?让我们根据最新的财务数据来看看 Astrana Health 的前景和价值,看看机会是否仍然存在。
What Is Astrana Health Worth?
Astrana Health 的价值是多少?
Astrana Health is currently expensive based on our price multiple model, where we look at the company's price-to-earnings ratio in comparison to the industry average. In this instance, we've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. We find that Astrana Health's ratio of 31.79x is above its peer average of 24.38x, which suggests the stock is trading at a higher price compared to the Healthcare industry. If you like the stock, you may want to keep an eye out for a potential price decline in the future. Given that Astrana Health's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.
根据我们的价格倍数模型,Astrana Health目前价格昂贵,在该模型中,我们将公司的市盈率与行业平均水平的比较来看。在这种情况下,鉴于没有足够的信息来可靠地预测股票的现金流,我们使用了市盈率(PE)。我们发现,Astrana Health的31.79倍的比率高于其同行平均水平的24.38倍,这表明该股的交易价格高于医疗保健行业。如果你喜欢这只股票,你可能需要留意未来潜在的价格下跌。鉴于Astrana Health的份额相当不稳定(即其价格相对于其他市场的价格变动被放大),这可能意味着价格可能会下跌,从而使我们有机会在未来再次买入。这是基于其高贝塔值,这是衡量股价波动的良好指标。
Can we expect growth from Astrana Health?
我们能指望 Astrana Health 的增长吗?
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to grow by 82% over the next couple of years, the future seems bright for Astrana Health. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.
寻求投资组合增长的投资者可能需要在购买公司股票之前考虑公司的前景。尽管价值投资者会争辩说,最重要的是相对于价格的内在价值,但更有说服力的投资论点是以低廉的价格获得高增长潜力。预计未来几年利润将增长82%,阿斯利康的前景似乎一片光明。看来该股的现金流即将增加,这应该会促进更高的股票估值。
What This Means For You
这对你意味着什么
Are you a shareholder? ASTH's optimistic future growth appears to have been factored into the current share price, with shares trading above industry price multiples. However, this brings up another question – is now the right time to sell? If you believe ASTH should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.
你是股东吗?ASTH乐观的未来增长似乎已被纳入当前股价的因素,股票的交易价格高于行业价格倍数。但是,这又带来了另一个问题——现在是合适的卖出时机吗?如果您认为ASTH的交易价格应低于其当前价格,那么高价卖出并在其价格跌至行业市盈率时再次回购可能会有利可图。但是在做出这个决定之前,先看看它的基本面是否发生了变化。
Are you a potential investor? If you've been keeping tabs on ASTH for some time, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the optimistic prospect is encouraging for ASTH, which means it's worth diving deeper into other factors in order to take advantage of the next price drop.
你是潜在的投资者吗?如果你关注ASTH已有一段时间了,那么现在可能不是入股的最佳时机。该价格已经超过了业内同行,这意味着错误定价可能没有更多的上行空间。但是,对于ASTH来说,乐观的前景令人鼓舞,这意味着值得深入研究其他因素,以便利用下一次价格下跌的机会。
In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. While conducting our analysis, we found that Astrana Health has 1 warning sign and it would be unwise to ignore this.
有鉴于此,如果你想对公司进行更多分析,了解所涉及的风险至关重要。在进行分析时,我们发现Astrana Health有1个警告信号,忽视这一点是不明智的。
If you are no longer interested in Astrana Health, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
如果您不再对Astrana Health感兴趣,可以使用我们的免费平台查看我们列出的其他50多只具有高增长潜力的股票清单。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。